Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Location: United States
Employees: 1-10
Total raised: $8M
Founded date: 1997
Investors 1
| Date | Name | Website |
| - | Redmont Ca... | redmontcap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.04.2015 | - | $8M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 02.04.2015 | Biotech firm Vaxin raises $8M [Startup Roundup] | WHO’S GETTING FUNDED? Gaithersburg, Md.-based Vaxin, a biotech company focused on developing “novel... | technical.... |
| - | Vaxin enters definitive agreement to acquire Immune Targetin... | Gaithersburg, Maryland – February 17, 2015 – Moving to advance its leadership in developing vaccines... | healthcap.... |
| - | VAXIN CEO TO PRESENT AT FUTURE LEADERS IN THE BIOTECH INDUST... | Gaithersburg, Maryland – March 17, 2015 – Vaxin, a clinical stage vaccine development company today ... | healthcap.... |
| - | VAXIN STRENGTHENS INTELLECTUAL PROPERTY PORTFOLIO | Gaithersburg, Maryland – July 21 2015- Vaxin Inc. today announced that it has added key patents to i... | healthcap.... |
| - | VAXIN CHANGES COMPANY NAME TO ALTIMMUNE | Move Reflects Company’s Expansion beyond Vaccines to Include Immunotherapeutics Gaithersburg, Maryl... | healthcap.... |
| - | Vaxin First-in-Man Phase I Clinical Trial Initiated in Chron... | Gaithersburg, Maryland – July 27 2015. Vaxin Inc., a clinical stage vaccine and immunotherapeutics c... | healthcap.... |